“I’m delighted to be able to work with the outstanding team at BenchSci who are broadly applying cutting edge AI technologies to accelerate the discovery of new therapeutics.”
Steve Hitchcock is the Chief Scientific Officer at Takeda Pharmaceuticals. He is responsible for the global research organization at Takeda across the four therapeutic areas of neuroscience, oncology, gastrointestinal diseases, and rare diseases. Hitchcock joined Takeda as part of their acquisition of Envoy Therapeutics, where he was the Chief Scientist and Senior Vice President of Drug Discovery. Before Takeda, he served in senior leadership positions in the research organizations at both Eli Lilly and Amgen. He also served as an adjunct professor in the Department of Molecular Therapeutics at Scripps Florida, a division of The Scripps Research Institute. Hitchcock completed a NATO postdoctoral fellowship at Yale University and holds a Ph.D. in organic chemistry from the University of Nottingham (U.K.).